Be careful about the risk of overdose. The National Agency for the Safety of Medicines and Health Products (ANSM) launched the alert this Wednesday, May 15, about Doliprane 2.4%, a drinkable syrup intended for infants and children.
It was the Opella Healthcare France laboratory that reported a problem with its product. More precisely, the “thirty” pipettes supplied in boxes do not have graduations. Therefore, it is not possible to measure the dose correctly.
“Do not use the non-graduated pipette or the pipette of another medication, to avoid the risk of making a dosing error,” the Agency indicates in its message.
The syrup is not the cause. The observed defect refers only to plastic pipettes.
More than 1.3 million boxes affected
Lots have been identified that may contain defective pipettes. These are: 3KLR12D1, 3KLR13D2, 3KLQ70DU, 3KLQ69DT, 3KLR14D3, 3KLQ71DV, 3KLQ72DW. “These lots add up to more than 1.3 million boxes,” specifies the ANSM.
Pharmacists will be instructed to check the pipette in front of the patient when dispensing the medication. Otherwise, it will be possible to exchange the defective box at the pharmacy if the lack of graduation is later found.
The instructions for patients who notice this defect are clear: “Do not use this pipette; nor use the pipette of another medication; return your box to the pharmacy, they will exchange it,” indicates the health authority.
The pipette manufacturer “claims to have taken measures to ensure that new batches do not contain this defect,” he adds.
Paracetamol overdose carries a risk of “serious poisoning (…) especially in young children,” explains Vidal. An overdose can therefore lead to drug-induced hepatitis requiring, for example, a liver transplant.
Source: BFM TV
